Leukaemia - A developmental perspective

British Journal of Haematology

Volumn 126, Issue 1, 2004, Pages 3-10

  Izraeli, Shai ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

GATA1; Leukaemia; RUNX1; SCL; Trisomy 21

Indexed keywords

HELIX LOOP HELIX PROTEIN; LIM DOMAIN PROTEIN 1; LIM DOMAIN PROTEIN 2; PROTEIN; PROTEIN SCL; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; CANCER GENETICS; CANCER GROWTH; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; COMBINED IMMUNODEFICIENCY; DOWN SYNDROME; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENETIC CODE; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMOGENESIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; TRANSIENT MYELOPROLIFERATIVE DISORDER;

CELL CYCLE; CELL DEATH; CELL DIVISION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION; HEMATOPOIESIS; HUMANS; LEUKEMIA; LEUKEMIA, T-CELL, ACUTE; METALLOPROTEINS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS;

EID: 3042829784     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04986.x     Document Type: Review

References (85)

1. Aplan, P.D., Lombardi, D.P., Ginsberg, A.M., Cossman, J., Bertness, V.L. & Kirsch, I.R. ( 1990) Disruption of the human SCL locus by 'illegitimate' V-(D)-J recombinase activity. Science, 250, 1426-1429.
2. Aplan, P.D., Lombardi, D.P., Reaman, G.H., Sather, H.N., Hammond, G.D. & Kirsch, I.R. (1992) Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood, 79, 1327-1333.
3. Aplan, P.D., Jones, C.A., Chervinsky, D.S., Zhao, X., Ellsworth, M., Wu, C., McGuire, E.A. & Gross, K.W. (1997) An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO Journal, 16, 2408-2419.
4. Arceci, R.J. (2002) Down syndrome, transient myeloproliferative syndrome, and leukemia: bridging development and neoplasia. Journal of Pediatric Hematology/Oncology, 24, 1.
5. Bain, G., Engel, I., Robanus Maandag, E.C., te Riele, H.P., Voland, J.R., Sharp, L.L., Chun, J., Huey, B., Pinkel, D. & Murre, C. (1997) E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Molecular and Cell Biology, 17, 4782-4791.
6. Begley, C.G., Aplan, P.D., Denning, S.M., Haynes, B.F., Waldmann, T.A. & Kirsch, I.R. (1989) The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proceedings of the National Academy of Sciences of the United States of America, 86, 10128-10132.
7. Busson-Le Coniat, M., Nguyen Khac, F., Daniel, M.T., Bernard, O.A. & Berger, R. (2001) Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer, 32, 244-249.
8. Cai, Z., de Bruijn, M., Ma, X., Dortland, B., Luteijn, T., Downing, R.J. & Dzierzak, E. (2000) Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity, 13, 423-431.
9. Calligaris, R., Bottardi, S., Cogoi, S., Apezteguia, I. & Santoro, C. (1995) Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proceedings of the National Academy of Sciences of the United States of America, 92, 11598-11602.
10. Cameron, E.R., Blyth, K., Hanlon, L., Kilbey, A., Mackay, N., Stewart, M., Terry, A., Vaillant, F., Wotton, S. & Neil, J.C. (2003) The Runx genes as dominant oncogenes. Blood Cells, Molecules, and Diseases, 30, 194-200.
11. Cantor, A.B. & Orkin, S.H. (2002) Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene, 21, 3368-3376.
12. Chang, A.N., Cantor, A.B., Fujiwara, Y., Lodish, M.B., Droho, S., Crispino, J.D. & Orkin, S.H. (2002) GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 99, 9237-9242.
13. Chervinsky, D.S., Zhao, X.F., Lam, D.H., Ellsworth, M., Gross, K.W. & Aplan, P.D. (1999) Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Molecular Cell Biology, 19, 5025-5035.
14. Dal Cin, P., Atkins, L., Ford, C., Ariyanayagam, S., Armstrong, S.A., George, R., Cleary, A. & Morton, C.C. (2001) Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes Cancer, 30, 407-409.
15. Downing, J.R. (1999) The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance. British Journal of Haematology, 106, 296-308.
16. Elagib, K.E., Racke, F.K., Mogass, M., Khetawat, R., Delehanty, L.L. & Goldfarb, A.N. (2003) RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood, 101, 4333-4341.
17. Engel, I., Johns, C., Bain, G., Rivera, R.R. & Murre, C. (2001) Early thymocyte development is regulated by modulation of E2A protein activity. Journal of Experimental Medicine, 194, 733-745.
18. Ferrando, A.A., Neuberg, D.S., Staunton, J., Loh, M.L., Huard, C., Raimondi, S.C., Behm, F.G., Pui, C.H., Downing, J.R., Gilliland, D.G., Lander, E.S., Golub, T.R. & Look, A.T. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell, 1, 75-87.
19. Ferrando, A.A., Herblot, S., Palomero, T., Hansen, M., Hoang, T., Fox, E.A. & Look, A.T. (2004) Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood, 103, 1909-1911.
20. Ford, A.M., Bennett, C.A., Price, C.M., Bruin, M.C., Van Wering, E.R. & Greaves, M. (1998) Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proceedings of the National Academy of Sciences of the United States of America, 95, 4584-4588.
21. Ford, A.M., Fasching, K., Panzer-Grumayer, E.R., Koenig, M., Haas, O.A. & Greaves, M.F. (2001) Origins of 'late' relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood, 98, 558-564.
22. Gering, M., Yamada, Y., Rabbitts, T.H. & Patient, R.K. (2003) Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development, 130, 6187-6199.
23. Greaves, M.F. (1988) Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia, 2, 120-125.
24. Groet, J., McElwaine, S., Spinelli, M., Rinaldi, A., Burtscher, I., Mulligan, C., Mensah, A., Cavani, S., Dagna-Bricarelli, F., Basso, G., Cotter, F.E. & Nizetic, D. (2003) Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet, 361, 1617-1620.
25. Guidez, F., Petrie, K., Ford, A.M., Lu, H., Bennett, C.A., MacGregor, A., Hannemann, J., Ito, Y., Ghysdael, J., Greaves, M., Wiedemann, L.M. & Zelent, A. (2000) Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood, 96, 2557-2561.
26. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., LeDeist, F., Fischer, A. & Cavazzana-Calvo, M. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415-419.
27. Harada, H., Harada, Y., Tanaka, H., Kimura, A. & Inaba, T. (2003) Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. Blood, 101, 673-680.
28. Harrison, C.J. (2001) The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Reviews, 15, 49-59.
29. Hasle, H. (2001) Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncology, 2, 429-436.
30. Hasle, H., Niemeyer, C.M., Chessells, J.M., Baumann, I., Bennett, J.M., Kerndrup, G. & Head, D.R. (2003) A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia, 17, 277-282.
31. Herblot, S., Steff, A.M., Hugo, P., Aplan, P.D. & Hoang, T. (2000) SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Natural Immunology, 1, 138-144.
32. Herblot, S., Aplan, P.D. & Hoang, T. (2002) Gradient of E2A activity in B-cell development. Molecular Cell Biology, 22, 886-900.
33. Hitzler, J.K. (2002) GATA1 - a player in normal and leukemic megakaryopoiesis. Pediatric Research, 52, 831.
34. Hitzler, J.K., Cheung, J., Li, Y., Scherer, S.W. & Zipursky, A. (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood, 101, 4301-4304.
35. Izraeli, S., Henn, T., Strobl, H., Ludwig, W.D., Kovar, H., Haas, O.A., Harbott, J., Bartram, C.R., Gadner, H. & Lion, T. (1993) Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia. Leukemia, 7, 2054-2056.
36. Izraeli, S., Colaizzo-Anas, T., Bertness, V.L., Mani, K., Aplan, P.D. & Kirsch, I.R. (1997) Expression of the SIL gene is correlated with growth induction and cellular proliferation. Cell Growth and Differentiation, 8, 1171-1179.
37. Kee, B.L., Quong, M.W. & Murre, C. (2000) E2A proteins: essential regulators at multiple stages of B-cell development. Immunological Reviews, 175, 138-149.
38. Kee, B.L., Bain, G. & Murre, C. (2002) IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO Journal, 21, 103-113.
39. Kempski, H.M. & Sturt, N.T. (2000) The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood. Leukemia and Lymphoma, 40, 39-47.
40. Lacaud, G., Gore, L., Kennedy, M., Kouskoff, V., Kingsley, P., Hogan, C., Carlsson, L., Speck, N., Palis, J. & Keller, G. (2002) Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood, 100, 458-466.
41. Lahlil, R., Lecuyer, E., Herblot, S. & Hoang, T. (2004) SCL Assembles a Multifactorial Complex That Determines Glycophorin A Expression. Molecular Cell Biology, 24, 1439-1452.
42. Larson, R.C., Lavenir, I., Larson, T.A., Baer, R., Warren, A.J., Wadman, I., Nottage, K. & Rabbitts, T.H. (1996) Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO Journal, 15, 1021-1027.
43. Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L. & Groner, Y. (1994) AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics, 23, 425-432.
44. McCormack, M.P., Forster, A., Drynan, L., Pannell, R. & Rabbitts, T.H. (2003) The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Molecular Cell Biology, 23, 9003-9013.
45. Mehaffey, M.G., Newton, A.L., Gandhi, M.J., Crossley, M. & Drachman, J.G. (2001) X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood, 98, 2681-2688.
46. Mikkola, H.K., Klintman, J., Yang, H., Hock, H., Schlaeger, T.M., Fujiwara, Y. & Orkin, S.H. (2003) Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature, 421, 547-551.
47. Mori, H., Colman, S.M., Xiao, Z., Ford, A.M., Healy, L.E., Donaldson, C., Hows, J.M., Navarrete, C. & Greaves, M. (2002) Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proceedings of the National Academy of Sciences of the United States of America, 99, 8242-8247.
48. Morrow, M., Horton, S., Kioussis, D., Brady, H.J. & Williams, O. (2004) TEL-AML1 promotes development of specific hematopoietic lineages consistent with pre-leukemic activity. Blood. [Epub ahead of print].
49. Mundschau, G., Gurbuxani, S., Gamis, A.S., Greene, M.E., Arceci, R.J. & Crispino, J.D. (2003) Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood. 101, 4298-4300.
50. Nichols, K.E., Crispino, J.D., Poncz, M., White, J.G., Orkin, S.H., Maris, J.M. & Weiss, M.J. (2000) Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Natural Genetics, 24, 266-270.
51. Orkin, S.H., Shivdasani, R.A., Fujiwara, Y. & McDevitt, M.A. (1998) Transcription factor GATA-1 in megakaryocyte development. Stem Cells, 16(Suppl. 2), 79-83.
52. Poirel, H., Lacronique, V., Mauchauffe, M., Le Coniat, M., Raffoux, E., Daniel, M.T., Erickson, P., Drabkin, H., MacLeod, R.A., Drexler, H.G., Ghysdael, J., Berger, R. & Bernard, O.A. (1998) Analysis of TEL proteins in human leukemias. Oncogene, 16, 2895-2903.
53. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F.W. & Orkin, S.H. (1996) The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell, 86, 47-57.
54. Porcher, C., Liao, E.C., Fujiwara, Y., Zon, L.I. & Orkin, S.H. (1999) Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development, 126, 4603-4615.
55. Preudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J.L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., Kerckaert, J.P., Cosson, A. & Fenaux, P. (2000) High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood, 96, 2862-2869.
56. Rabbitts, T.H., Bucher, K., Chung, G., Grutz, G., Warren, A. & Yamada, Y. (1999) The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development. Cancer Research, 59, 1794s-1798s.
57. Rainis, L., Bercovich, D., Strehl, S., Teigler-Schlegel, A., Stark, B., Trka, J., Amariglio, N., Biondi, A., Muler, I., Rechavi, G., Kempski, H., Haas, O.A. & Izraeli, S. (2003) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood. 102, 981-986.
58. Robinson, H.M., Broadfield, Z.J., Cheung, K.L., Harewood, L., Harris, R.L., Jalali, G.R., Martineau, M., Moorman, A.V., Taylor, K.E., Richards, S., Mitchell, C. & Harrison, C.J. (2003) Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia, 17, 2249-2250.
59. Romana, S.P., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R. & Bernard, O.A. (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood, 85, 3662-3670.
60. Rubnitz, J.E., Pui, C.H. & Downing, J.R. (1999) The role of TEL fusion genes in pediatric leukemias. Leukemia, 13, 6-13.
61. Shivdasani, R.A., Mayer, E.L. & Orkin, S.H. (1995) Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/ SCL. Nature, 373, 432-434.
62. Shivdasani, R.A., Fujiwara, Y., McDevitt, M.A. & Orkin, S.H. (1997) A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO Journal, 16, 3965-3973.
63. Silva, F.P., Morolli, B., Storlazzi, C.T., Anelli, L., Wessels, H., Bezrookove, V., Kluin-Nelemans, H.C. & Giphart-Gassler, M. (2003) Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene, 22, 538-547.
64. Song, W.J., Sullivan, M.G., Legare, R.D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I.C., Haworth, C., Hock, R., Loh, M., Felix, C., Roy, D.C., Busque, L., Kurnit, D., Willman, C., Gewirtz, A.M., Speck, N.A., Bushweller, J.H., Li, P.P., Gardiner, K., Poncz, M., Maris, J.M. & Gilliland, D.G. (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Natural Genetics, 23, 166-175.
65. Speck, N.A. & Gilliland, D.G. (2002) Core-binding factors in haematopoiesis and leukaemia. Natural Reviews in Cancer, 2, 502-513.
66. Sun, L., Mao, G. & Rao, A.K. (2004) Association of CBFA2 mutation with decreased platelet PKC-theta and impaired receptor-mediated activation of GPIIb-IIIa and pleckstrin phosphorylation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation. Blood, 103, 948-954.
67. Tremblay, M., Herblot, S., Lecuyer, E. & Hoang, T. (2003) Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL. Journal of Biological Chemistry, 278, 12680-12687.
68. Visvader, J.E., Mao, X., Fujiwara, Y., Hahm, K. & Orkin, S.H. (1997) The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proceedings of the National Academy of Sciences of the United States of America, 94, 13707-13712.
69. Visvader, J.E., Fujiwara, Y. & Orkin, S.H. (1998) Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes and Development, 12, 473-479.
70. Wadman, I.A., Osada, H., Grutz, G.G., Agulnick, A.D., Westphal, H., Forster, A. & Rabbitts, T.H. (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO Journal, 16, 3145-3157.
71. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H. & Speck, N.A. (1996a) Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 93, 3444-3449.
72. Wang, Q., Stacy, T., Miller, J.D., Lewis, A.F., Gu, T.L., Huang, X., Bushweller, J.H., Bories, J.C., Alt, F.W., Ryan, G., Liu, P.P., Wynshaw-Boris, A., Binder, M., Marin-Padilla, M., Sharpe, A.H. & Speck, N.A. (1996b) The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell, 87, 697-708.
73. Wang, L.C., Swat, W., Fujiwara, Y., Davidson, L., Visvader, J., Kuo, F., Alt, F.W., Gilliland, D.G., Golub, T.R. & Orkin, S.H. (1998) The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes and Develpment, 12, 2392-2402.
74. Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. & Crispino, J.D. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Natural Genetics, 32, 148-152.
75. Wiemels, J.L., Cazzaniga, G., Daniotti, M., Eden, O.B., Addison, G.M., Masera, G., Saha, V., Biondi, A. & Greaves, M.F. (1999) Prenatal origin of acute lymphoblastic leukaemia in children. Lancet, 354, 1499-1503.
76. Xu, Z., Huang, S., Chang, L.S., Agulnick, A.D. & Brandt, S.J. (2003) Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldbl in erythroid gene expression and differentiation. Molecular Cell Biology, 23, 7585-7599.
77. Yamada, Y., Warren, A.J., Dobson, C., Forster, A., Pannell, R. & Rabbitts, T.H. (1998) The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 95, 3890-3895.
78. Yan, W., Young, A.Z., Soares, V.C., Kelley, R., Benezra, R. & Zhuang, Y. (1997) High incidence of T-cell tumors in E2A-null mice and E2A/ Id1 double-knockout mice. Molecular Cell Biology, 17, 7317-7327.
79. Yu, C., Cantor, A.B., Yang, H., Browne, C., Wells, R.A., Fujiwara, Y. & Orkin, S.H. (2002a) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. Journal of Experimental Medicine, 195, 1387-1395.
80. Yu, C., Niakan, K.K., Matsushita, M., Stamatoyannopoulos, G., Orkin, S.H. & Raskind, W.H. (2002b) X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood, 100, 2040-2045.
81. Zipursky, A. (2003) Transient leukaemia - a benign form of leukaemia in newborn infants with trisomy 21. British Journal of Haematology, 120, 930-938.
82. Zipursky, A., Peeters, M. & Poon, A. (1987) Megakaryoblastic leukemia and Down's syndrome: a review. Pediatric Hematology/Oncology, 4, 211-230.
83. Zipursky, A., Poon, A. & Doyle, J. (1992) Leukemia in Down syndrome: a review. Pediatric Hematology/Oncology, 9, 139-149.
84. Zipursky, A., Brown, E., Christensen, H., Sutherland, R. & Doyle, J. (1997) Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Seminars in Perinatology, 21, 97-101.
85. Zipursky, A., Brown, E.J., Christensen, H. & Doyle, J. (1999) Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clinics in Laboratory Medicine, 19, 157-167, vii.